Reviewing the Standard of Care for Patients with Nonmetastatic Castration-Resistant Disease

Expert panelist provides his perspective on a CRPC patient case before discussing the typical course of treatment for patients with nonmetastatic CRPC.

EP: 1.A 57-Year-Old Man with Nonmetastatic Castration-Resistant Disease

Now Viewing

EP: 2.Reviewing the Standard of Care for Patients with Nonmetastatic Castration-Resistant Disease

EP: 3.The Use of Darolutamide in Patients with Castration-Resistant Prostate Cancer

EP: 4.The Evolving Castration-Resistant Prostate Cancer Treatment Landscape

Recent Videos